TROP2 expression
TROP2 expression
|
Non Small Cell Lung Cancer
NSCLC
|
TROP2 expression
TROP2 expression
|
Non Small Cell Lung Cancer
NSCLC
|
DS-1062a
Sensitive: C2 – Inclusion Criteria
|
DS-1062a
Sensitive: C2 – Inclusion Criteria
|
TROP2 expression
TROP2 expression
|
Cervical Cancer
Cervical Cancer
|
TROP2 expression
TROP2 expression
|
Cervical Cancer
Cervical Cancer
|
sacituzumab govitecan-hziy
Sensitive: D – Preclinical
|
sacituzumab govitecan-hziy
Sensitive: D – Preclinical
|
TROP2 expression
TROP2 expression
|
Breast Cancer
Breast Cancer
|
TROP2 expression
TROP2 expression
|
Breast Cancer
Breast Cancer
|
DS-1062a
Sensitive: D – Preclinical
|
DS-1062a
Sensitive: D – Preclinical
|
TROP2 expression
TROP2 expression
|
HER2 Positive Breast Cancer
HER2 Positive Breast Cancer
|
TROP2 expression
TROP2 expression
|
HER2 Positive Breast Cancer
HER2 Positive Breast Cancer
|
neratinib
Sensitive: D – Preclinical
|
neratinib
Sensitive: D – Preclinical
|
TROP2 expression
TROP2 expression
|
HER2 Positive Breast Cancer
HER2 Positive Breast Cancer
|
TROP2 expression
TROP2 expression
|
HER2 Positive Breast Cancer
HER2 Positive Breast Cancer
|
lapatinib
Sensitive: D – Preclinical
|
lapatinib
Sensitive: D – Preclinical
|
